US20010044139A1 - Method for producing L-phenylalanine - Google Patents

Method for producing L-phenylalanine Download PDF

Info

Publication number
US20010044139A1
US20010044139A1 US09/791,707 US79170701A US2001044139A1 US 20010044139 A1 US20010044139 A1 US 20010044139A1 US 79170701 A US79170701 A US 79170701A US 2001044139 A1 US2001044139 A1 US 2001044139A1
Authority
US
United States
Prior art keywords
phenylalanine
fluorophenylalanine
resistant
bacterium
analog
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US09/791,707
Other versions
US6350596B2 (en
Inventor
Yurgis Antanas Iomantas
Elena Abalakina
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Assigned to AJINOMOTO CO., INC reassignment AJINOMOTO CO., INC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ABALAKINA, ELENA GEORGIEVNA, IOMANTAS, YURGIS ANTANAS VLADOVICH
Publication of US20010044139A1 publication Critical patent/US20010044139A1/en
Application granted granted Critical
Publication of US6350596B2 publication Critical patent/US6350596B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/22Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
    • C12P13/222Phenylalanine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Definitions

  • the present invention relates to a method for producing L-phenylalanine, in particular, to a bacterium belonging to the genus Methylophilus and having an ability to produce L-phenylalanine and a method for producing L-phenylalanine using a bacterium belonging to the genus Methylophilus.
  • An object of the present invention is to provide a bacterium having an ability to produce L-phenylalanine and a method for producing L-phenylalanine by using the bacterium.
  • the present inventors have found that a bacterium belonging to the genus Methylophilus which is resistant to a phenylalanine analog, has a high ability to produce L-phenylalanine. Based on the finding, the present invention has been accomplished.
  • the present invention provides a bacterium belonging to the genus Methylophilus, which has an ability to produce L-phenylalanine and is resistant to a phenylalanine analog (hereinafter, also referred to as “bacterium of the present invention”).
  • the bacterium of the present invention is preferably resistant to the phenylalanine analog and L-phenylalanine.
  • the bacterium of the present invention is preferably resistant to DL-p-fluorophenylalanine.
  • the bacterium of the present invention is preferably obtained by selecting a strain which is resistant to the phenylalanine analog and L-phenylalanine from bacteria belonging to the genus Methylophilus, wherein said selection is performed at least once for each of the phenylalanine analog and L-phenylalanine in any order.
  • the bacterium of the present invention is more preferably resistant to DL-p-fluorophenylalanine and m-fluorophenylalanine, as well as to L-phenylalanine.
  • the bacterium of the present invention is more preferably obtained by selecting a strain which is resistant to DL-p-fluorophenylalanine, m-fluorophenylalanine and L-phenylalanine from bacteria belonging to the genus Methylophilus, wherein said selection is performed at least once for each of DL-p-fluorophenylalanine, m-fluorophenylalanine and L-phenylalanine in any order.
  • the bacterium of the present invention is preferably resistant to DL-p-fluorophenylalanine, m-fluorophenylalanine and cinnamic acid, as well as L-phenylalanine.
  • the bacterium of the present invention is more preferably obtained by selecting a strain which is resistant to DL-p-fluorophenylalanine, m-fluorophenylalanine, cinnamic acid and L-phenylalanine from bacteria belonging to the genus Methylophilus, wherein said selection is performed at least once for each of DL-p-fluorophenylalanine, m-fluorophenylalanine, cinnamic acid and L-phenylalanine in any order.
  • the bacterium of the present invention is preferably Methylophilus methylotrophus.
  • the present invention also provides a method for producing L-phenylalanine, comprising the steps of:
  • the bacterium of the present invention is a bacterium belonging to the genus Methylophilus, which has an ability to produce L-phenylalanine and is resistant to a phenylalanine analog, and preferably to the phenylalanine analog and L-phenylalanine.
  • the bacterium belonging to the genus Methylophilus includes Methylophilus methylotrophus.
  • the ability to produce L-phenylalanine means an ability to accumulate a significant amount of L-phenylalanine in a medium when the bacterium is cultured in the medium. Usually, it means an ability to accumulate not less than 0.5 g/l of L-phenylalanine under the conditions described in Examples mentioned below.
  • Examples of the phenylalanine analog are DL-p-fluorophenylalanine, m-fluorophenylalanine, ⁇ -amino- ⁇ -phenylpropionic acid, o-fluorophenylalanine, ⁇ -2-thienylalanine, ⁇ -3-thienylalanine, ⁇ -2-furylalanine, ⁇ -3-furylalanine, o-aminophenylalanine, p-aminophenylalanine, m-aminophenylalanine, ⁇ -amino- ⁇ -phenylethanesulfonate, ⁇ -2-pyrrolalanine, 1-cyclopentene-1-alanine, 1-cyclohexene-1-alanine, ⁇ -4-pyridylalanine, ⁇ -4-pyrazolylalanine, p-nitro-phenylalanine, cyclohexylalanine, o-chlorophenyla
  • To be resistant to an phenylalanine analog means that the bacterium can grow in the presence of the phenylalanine analog in the amount at which the wild type strain (for example, strain AS-1) can not grow.
  • the amount varies depending on the kinds of the phenylalanine analog. In the case of DL-p-fluorophenylalanine, it is usually 2 g/l under the conditions described in Examples mentioned below, and in the case of m-fluorophenylalanine, it is usually 1 g/l under the conditions described in Examples mentioned below.
  • the bacterium of the present invention is resistant to at least two kinds of the phenylalanine analog.
  • To be resistant to L-phenylalanine means that the bacterium can grow in the presence of L-phenylalanine in the amount at which the wild type strain (for example, strain AS-1) can not grow.
  • the amount is usually 8 g/l under the conditions described in Examples mentioned below.
  • the bacterium of the present invention is preferably resistant to a higher concentration (for example, 0.1 M) of L-phenylalanine.
  • the bacterium of the present invention can be obtained by conferring the required resistances to a bacterium belonging to the genus Methylophilus in order.
  • the order of conferring the phenylalanine analog resistance and the L-phenylalanine resistance is not limited and the conferring may be made in any order.
  • the bacteria belonging to the genus Methylophilus which is resistant to a phenylalanine analog can be obtained by culturing bacteria belonging to the genus Methylophilus in a minimal medium containing the phenylalanine analog at the growth inhibitory concentration and selecting a growing strain.
  • the selection of the phenylalanine-analog-resistant strain may be performed with one kind of the phenylalanine analog, or with more kinds of the phenylalanine analogs.
  • the selection of the strain may be performed once or more for one kind of the phenylalanine analog.
  • An amount of the phenylalanine analog which is to be added to the medium depends on a kind of the phenylalanine analog, but is preferably not less than 2 g/L in the case of DL-p-fluorophenylalanine.
  • the bacteria belonging to the genus Methylophilus may be subjected to a mutation treatment prior to the selection. Mutation may be performed by ultraviolet irradiation or by treatment with a mutagen usually used for artificial mutagenesis such as N-methyl-N′-nitro-N-nitrosoguanidine (NTG) or nitrous acid and the like.
  • the bacteria belonging to the genus Methylophilus which is resistant to L-phenylalanine can be obtained by culturing bacteria belonging to the genus Methylophilus in a minimal medium containing L-phenylalanine at the concentration that causes growth inhibition, and selecting a growing strain. Growth inhibition herein refers to slow growth or stop of growth. The selection of the strains may be performed once or more.
  • a concentration of L-phenylalanine in the medium is not particularly limited, but it is exemplified by not less than 0.05 M, preferably 0.1 M.
  • the bacteria belonging to the genus Methylophilus may be subjected to a mutation treatment prior to the selection in the same manner as described above.
  • the bacterium belonging to the genus Methylophilus which is resistant to L-phenylalanine, obtained as mentioned above, can grow in the presence of L-phenylalanine at a concentration at which its parent strain can not grow.
  • the bacterium of the present invention is preferably resistant to cinnamic acid.
  • To be resistant to cinnamic acid means that the bacterium can grow in the presence of cinnamic acid in the amount at which the wild type strain (for example, strain AS-1) can not grow.
  • the amount is usually 50 mg/l under the conditions described in Examples mentioned below.
  • the bacteria belonging to the genus Methylophilus which is resistant to cinnamic acid can be obtained by a similar way to that for phenylalanine analog-resistant bacteria.
  • the order of conferring the cinnamic acid resistance, the phenylalanine analog resistance and the L-phenylalanine resistance is not limited and the conferring may be made in any order.
  • L-Phenylalanine is concerned with several regulation steps on L-phenylalanine biosynthesis. Therefore, single mutation which causes L-phenylalanine resistance may be effective for improvement of L-phenylalanine productivity, however, it is preferably that more regulations are desensitized by double or more mutations.
  • a bacterium belonging to the genus Methylophilus which has single mutation can be used as a starting source for breeding of an L-phenylalanine-producing strain, even though its productivity of L-phenylalanine is low.
  • the bacterium of the present invention may be enhanced in activity of one or more enzymes of L-phenylalanine biosynthetic pathway by usual mutation treatment or genetic engineering techniques.
  • L-phenylalanine biosynthesis can be enhanced by increasing an ability to produce phosphoenol pyruvate in a bacterium belonging to the genus Methylophilus (International Publication No. WO 97/08333).
  • L-Phenylalanine productivity is improved by enhancing a desensitized chorismate mutase-prephenate dehydratase gene (Japanese Patent Application Laid-Open Nos. 5-236947 and 62-130693), and/or a desensitized 3-deoxyl-D-arabino-hepturosonic acid 7-phosphate synthase gene (Japanese Patent Application Laid-Open Nos. 5-236947 and 61-124375).
  • the method of the present invention is a method for producing L-phenylalanine comprising cultivating the bacterium of the present invention in a culture medium, to produce and accumulate L-phenylalanine in a culture, and recovering L-phenylalanine from the culture.
  • the cultivation of the bacterium of the present invention may be performed by the method which is usually used for cultivation of methanol-assimilating microorganisms.
  • the culture medium used in the present invention may be either a synthetic medium or a natural medium, so long as the medium includes a carbon source, a nitrogen source and mineral nutrients and, if necessary, other organic micronutrients.
  • Methanol is usually added to the culture medium usually in amount of 0.001 to 30% by weight, when it is used as a main carbon source.
  • nitrogen source ammonium sulfate may be used by adding it to the culture medium.
  • mineral nutrients such as potassium phosphate, sodium phosphate, magnesium sulfate, ferrous sulfate, and manganese sulfate may be used.
  • the cultivation is performed usually under aerobic conditions such as shaking culture and aeration and stirring culture, at pH of 5 to 9, and at a temperature of 20 to 40° C. It is usually completed for 24 to 120 hours.
  • the culture includes cells and the culture medium, and is preferably the culture medium.
  • the recover of L-phenylalanine from the culture may be performed according to combination of known methods such as ionexchange resin method and precipitation method.
  • the strain was grown on plates or slants with 121(Fe2)-medium agar containing 1% methanol at 30° C. for 48-72 hours. And then the strain was inoculated into 5 ml 121(Fe2)-medium containing 2% methanol used as the seed medium in tubes with capacity of 40 ml. The seed culture was incubated on a rotary shaker at 37° C. for 18 hours.
  • L-phenylalanine producer was carried out at 37° C. in 5 ml of 121(Fe2)-medium containing 2% methanol and 3% calcium carbonate in tubes with capacity of 40 ml. Twenty four hours after the start of cultivation, the another portion of 2% methanol was added and the cultivation was continued for further 48 hours at 37° C. on a rotary shaker.
  • the chromatographic system consisted of a HPLC pump model 30 (Gilson), and model 2151 variable wavelength monitor operated at 245 nm (LKB). Samples were injected using model 7410 injector with 1 ⁇ l internal sample loop (Rheodyne). Column was thermostated with laboratory made water-jacketed thermostat at 45° C.
  • the Methylophilus methylotrophus AS-1 (NCIB 10515; ATCC 53528) strain was tested for the sensivity to the DL-p-fluorophenylalanine, an aromatic amino acid analog.
  • the sensivity has been tested on 121(Fe2)-agar medium containing different concentrations of DL-p-fluorophenylalanine.
  • the 10 8 c.f.u./ml of M. methylotrophus bacteria were plated and grown at +30° C. for 3 days. The 1 mg/ml of the DL-p-fluorophenylalanine totally inhibited the growth of the bacteria lawn. To select the analog-resistant mutants, the 10 8 bacteria of M.
  • methylotrophus strain was seeded on plates carrying 2 mg/ml of DL-p-fluorophenylalanine.
  • the several crystals of N-methyl-N′-nitro-N-nitrosoguanidin (hereinafter abbreviated to NG) mutagen was placed in the middle of the plate. After 4-5 days at 30° C., the plates were analyzed. The bacteria did not show growth near NG mutagen, but at 3-4 cm from it, the analog resistant mutant colonies grew. The big colonies were picked up and purified on the same media with analog DL-p-fluorophenylalanine. The M.
  • pFp R methylotrophus DL-p-fluorophenylalanine resistant mutants were cultivated and concentration of L-phenylalanine in the fermentation medium was measured as described above.
  • the Methylophilus methylotrophus DL-p-fluorophenylalanine resistant mutants produced L-phenylalanine but was sensitive to the high concentrations of L-phenylalanine if it was presented in the medium.
  • the 0.1 M of L-phenylalanine totally inhibited the growth of the M. methylotrophus pFp R mutant No. 227 if it was added into the agarized 121-medium.
  • the mutants resistant to the higher concentrations of L-phenylalanine presented in growing medium were selected.
  • the M. methylotrophus No. 227 (pFp R mutant strain) producing a little amount (30 mg/l) of L-phenylalanine was used.
  • the selection medium was the 121(Fe2)-agar medium with 1% methanol and 0.05 M L-phenylalanine.
  • the mutagenesis by NG was performed as it was described above.
  • the L-phenylalanine resistant mutant colonies were several times purified on the same medium and later on medium without 0.05 M of L-phenylalanine.
  • the phe R -marker in mutants was stable inherited and not lost without selection pressure.
  • the selected M. methylotrophus pFp R phe R mutants were cultivated and the concentration of L-phenylalanine in the fermentation medium was measured as described above.
  • the best M. methylotrophus pFp R phe R mutant No. 227-16 carrying the mutation of the resistance to the high L-phenylalanine concentrations produced 0.4 g/l of L-phenylalanine.
  • the phe R -mutation as the second mutation in M.
  • methylotrophus pFp R phe R mutant No. 227-16 elevated the L-phenylalanine production more than 10 times: the pFp R -mutant (No. 227) produced 30 mg/l of L-phenylalanine and the double pFp R phe R -mutant (No. 227-16) produced 400 mg/l of L-phenylalanine.
  • the phe RR -mutant strain produced in tubes 0.5-0.7 g/l L-phenylalanine, 0.3 g/l L-valine, 0.2 g/l L-leucine and less than 0.1 g/l of L-isoleucine, L-alanine and L-glutamic acid.
  • the cin R -mutant strain produced in tubes 0.8-0.9 g/l L-phenylalanine and 0.6 g/l L-valine.
  • strains Nos. 227, 227-16, 227-16-10, 227-16-10-11 and 227-16-10-11-cin8 have been deposited in the Russian National Collection of Industrial Microorganisms (VKPM) on Feb. 10 th , 2000 (converted to a deposition according to the provisions of Budapest Treaty on Jul. 18, 2000) under the accession numbers VKPMB-7909, VKPMB-7910, VKPM B-7911, VKPM B-7912, and VKPM B-7913, respectively.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A method for producing L-phenylalanine, comprising the steps of:
culturing a bacterium belonging to the genus Methylophilus which has an ability to produce L-phenylalanine and is resistant to a phenylalanine analog, in a culture medium to produce and accumulate L-phenylalanine in a culture, and
recovering L-phenylalanine from the culture.

Description

    BACKGROUND OF THE INVENTION
  • The present invention relates to a method for producing L-phenylalanine, in particular, to a bacterium belonging to the genus Methylophilus and having an ability to produce L-phenylalanine and a method for producing L-phenylalanine using a bacterium belonging to the genus Methylophilus. [0001]
  • As a method for producing L-phenylalanine by using a microorganism by fermentation, those using recombinant bacteria belonging to the genus Escherichia (Japanese Patent Application Laid-Open Nos. 56-1890, 57-170184, 58-103398, 61-92565 and 1-104160, and International Publication No. WO 87/00202) are known. As a method for producing L-phenylalanine or L-tyrosine, one using a mutant belonging to the genus Corynebacterium (Japanese Patent Application Laid-Open No. 61-128897), and those using recombinant bacteria belonging to the genus Corynebacterium (Japanese Patent Application Laid-Open Nos. 60-34197, 60-24192, 61-260892, and 61-124375) are known. [0002]
  • However, production of L-phenylalanine by using a bacterium belonging to the genus Methylophilus is not known. [0003]
  • SUMMARY OF THE INVENTION
  • An object of the present invention is to provide a bacterium having an ability to produce L-phenylalanine and a method for producing L-phenylalanine by using the bacterium. [0004]
  • The present inventors have found that a bacterium belonging to the genus Methylophilus which is resistant to a phenylalanine analog, has a high ability to produce L-phenylalanine. Based on the finding, the present invention has been accomplished. [0005]
  • The present invention provides a bacterium belonging to the genus Methylophilus, which has an ability to produce L-phenylalanine and is resistant to a phenylalanine analog (hereinafter, also referred to as “bacterium of the present invention”). [0006]
  • The bacterium of the present invention is preferably resistant to the phenylalanine analog and L-phenylalanine. [0007]
  • The bacterium of the present invention is preferably resistant to DL-p-fluorophenylalanine. [0008]
  • The bacterium of the present invention is preferably obtained by selecting a strain which is resistant to the phenylalanine analog and L-phenylalanine from bacteria belonging to the genus Methylophilus, wherein said selection is performed at least once for each of the phenylalanine analog and L-phenylalanine in any order. [0009]
  • The bacterium of the present invention is more preferably resistant to DL-p-fluorophenylalanine and m-fluorophenylalanine, as well as to L-phenylalanine. [0010]
  • The bacterium of the present invention is more preferably obtained by selecting a strain which is resistant to DL-p-fluorophenylalanine, m-fluorophenylalanine and L-phenylalanine from bacteria belonging to the genus Methylophilus, wherein said selection is performed at least once for each of DL-p-fluorophenylalanine, m-fluorophenylalanine and L-phenylalanine in any order. [0011]
  • The bacterium of the present invention is preferably resistant to DL-p-fluorophenylalanine, m-fluorophenylalanine and cinnamic acid, as well as L-phenylalanine. [0012]
  • The bacterium of the present invention is more preferably obtained by selecting a strain which is resistant to DL-p-fluorophenylalanine, m-fluorophenylalanine, cinnamic acid and L-phenylalanine from bacteria belonging to the genus Methylophilus, wherein said selection is performed at least once for each of DL-p-fluorophenylalanine, m-fluorophenylalanine, cinnamic acid and L-phenylalanine in any order. [0013]
  • The bacterium of the present invention is preferably [0014] Methylophilus methylotrophus.
  • The present invention also provides a method for producing L-phenylalanine, comprising the steps of: [0015]
  • culturing the bacterium of the present invention in a culture medium to produce and accumulate L-phenylalanine in a culture, and [0016]
  • recovering L-phenylalanine from the culture (hereinafter, also referred to as “method of the present invention). [0017]
  • DETAILED DESCRIPTION OF THE INVENTION
  • <1> The bacterium of the Present Invention [0018]
  • The bacterium of the present invention is a bacterium belonging to the genus Methylophilus, which has an ability to produce L-phenylalanine and is resistant to a phenylalanine analog, and preferably to the phenylalanine analog and L-phenylalanine. [0019]
  • The bacterium belonging to the genus Methylophilus includes [0020] Methylophilus methylotrophus.
  • The ability to produce L-phenylalanine means an ability to accumulate a significant amount of L-phenylalanine in a medium when the bacterium is cultured in the medium. Usually, it means an ability to accumulate not less than 0.5 g/l of L-phenylalanine under the conditions described in Examples mentioned below. [0021]
  • Examples of the phenylalanine analog are DL-p-fluorophenylalanine, m-fluorophenylalanine, β-amino-β-phenylpropionic acid, o-fluorophenylalanine, β-2-thienylalanine, β-3-thienylalanine, β-2-furylalanine, β-3-furylalanine, o-aminophenylalanine, p-aminophenylalanine, m-aminophenylalanine, α-amino-β-phenylethanesulfonate, β-2-pyrrolalanine, 1-cyclopentene-1-alanine, 1-cyclohexene-1-alanine, β-4-pyridylalanine, β-4-pyrazolylalanine, p-nitro-phenylalanine, cyclohexylalanine, o-chlorophenylalanine, m-chlorophenylalanine, p-chlorophenylalanine, o-bromophenylalanine, m-bromophenylalanine, p-bromophenylalanine, β-4-thiazolealanine and the like. [0022]
  • To be resistant to an phenylalanine analog means that the bacterium can grow in the presence of the phenylalanine analog in the amount at which the wild type strain (for example, strain AS-1) can not grow. The amount varies depending on the kinds of the phenylalanine analog. In the case of DL-p-fluorophenylalanine, it is usually 2 g/l under the conditions described in Examples mentioned below, and in the case of m-fluorophenylalanine, it is usually 1 g/l under the conditions described in Examples mentioned below. [0023]
  • It is preferred that the bacterium of the present invention is resistant to at least two kinds of the phenylalanine analog. For example, it is preferred that it is resistant to DL-p-fluorophenylalanine and m-fluorophenylalanine. [0024]
  • To be resistant to L-phenylalanine means that the bacterium can grow in the presence of L-phenylalanine in the amount at which the wild type strain (for example, strain AS-1) can not grow. The amount is usually 8 g/l under the conditions described in Examples mentioned below. [0025]
  • The bacterium of the present invention is preferably resistant to a higher concentration (for example, 0.1 M) of L-phenylalanine. [0026]
  • The bacterium of the present invention can be obtained by conferring the required resistances to a bacterium belonging to the genus Methylophilus in order. The order of conferring the phenylalanine analog resistance and the L-phenylalanine resistance is not limited and the conferring may be made in any order. [0027]
  • The method of obtaining a bacterium belonging to the genus Methylophilus which is resistant to the phenylalanine analog and a bacterium belonging to the genus Methylophilus which is resistant to L-phenylalanine will be explained below. [0028]
  • The bacteria belonging to the genus Methylophilus which is resistant to a phenylalanine analog can be obtained by culturing bacteria belonging to the genus Methylophilus in a minimal medium containing the phenylalanine analog at the growth inhibitory concentration and selecting a growing strain. [0029]
  • The selection of the phenylalanine-analog-resistant strain may be performed with one kind of the phenylalanine analog, or with more kinds of the phenylalanine analogs. The selection of the strain may be performed once or more for one kind of the phenylalanine analog. [0030]
  • An amount of the phenylalanine analog which is to be added to the medium depends on a kind of the phenylalanine analog, but is preferably not less than 2 g/L in the case of DL-p-fluorophenylalanine. The bacteria belonging to the genus Methylophilus may be subjected to a mutation treatment prior to the selection. Mutation may be performed by ultraviolet irradiation or by treatment with a mutagen usually used for artificial mutagenesis such as N-methyl-N′-nitro-N-nitrosoguanidine (NTG) or nitrous acid and the like. [0031]
  • The bacteria belonging to the genus Methylophilus which is resistant to L-phenylalanine can be obtained by culturing bacteria belonging to the genus Methylophilus in a minimal medium containing L-phenylalanine at the concentration that causes growth inhibition, and selecting a growing strain. Growth inhibition herein refers to slow growth or stop of growth. The selection of the strains may be performed once or more. A concentration of L-phenylalanine in the medium is not particularly limited, but it is exemplified by not less than 0.05 M, preferably 0.1 M. The bacteria belonging to the genus Methylophilus may be subjected to a mutation treatment prior to the selection in the same manner as described above. [0032]
  • The bacterium belonging to the genus Methylophilus which is resistant to L-phenylalanine, obtained as mentioned above, can grow in the presence of L-phenylalanine at a concentration at which its parent strain can not grow. [0033]
  • The bacterium of the present invention is preferably resistant to cinnamic acid. [0034]
  • To be resistant to cinnamic acid means that the bacterium can grow in the presence of cinnamic acid in the amount at which the wild type strain (for example, strain AS-1) can not grow. The amount is usually 50 mg/l under the conditions described in Examples mentioned below. [0035]
  • The bacteria belonging to the genus Methylophilus which is resistant to cinnamic acid can be obtained by a similar way to that for phenylalanine analog-resistant bacteria. The order of conferring the cinnamic acid resistance, the phenylalanine analog resistance and the L-phenylalanine resistance is not limited and the conferring may be made in any order. [0036]
  • L-Phenylalanine is concerned with several regulation steps on L-phenylalanine biosynthesis. Therefore, single mutation which causes L-phenylalanine resistance may be effective for improvement of L-phenylalanine productivity, however, it is preferably that more regulations are desensitized by double or more mutations. A bacterium belonging to the genus Methylophilus which has single mutation can be used as a starting source for breeding of an L-phenylalanine-producing strain, even though its productivity of L-phenylalanine is low. [0037]
  • The bacterium of the present invention may be enhanced in activity of one or more enzymes of L-phenylalanine biosynthetic pathway by usual mutation treatment or genetic engineering techniques. [0038]
  • For example, L-phenylalanine biosynthesis can be enhanced by increasing an ability to produce phosphoenol pyruvate in a bacterium belonging to the genus Methylophilus (International Publication No. WO 97/08333). [0039]
  • L-Phenylalanine productivity is improved by enhancing a desensitized chorismate mutase-prephenate dehydratase gene (Japanese Patent Application Laid-Open Nos. 5-236947 and 62-130693), and/or a desensitized 3-deoxyl-D-arabino-hepturosonic acid 7-phosphate synthase gene (Japanese Patent Application Laid-Open Nos. 5-236947 and 61-124375). [0040]
  • <2> The Method of the Present Invention [0041]
  • The method of the present invention is a method for producing L-phenylalanine comprising cultivating the bacterium of the present invention in a culture medium, to produce and accumulate L-phenylalanine in a culture, and recovering L-phenylalanine from the culture. [0042]
  • The cultivation of the bacterium of the present invention may be performed by the method which is usually used for cultivation of methanol-assimilating microorganisms. The culture medium used in the present invention may be either a synthetic medium or a natural medium, so long as the medium includes a carbon source, a nitrogen source and mineral nutrients and, if necessary, other organic micronutrients. [0043]
  • If methanol is used as a main carbon source, L-phenylalanine can be produced inexpensively. Methanol is usually added to the culture medium usually in amount of 0.001 to 30% by weight, when it is used as a main carbon source. As the nitrogen source, ammonium sulfate may be used by adding it to the culture medium. In addition to these, a small amount of mineral nutrients such as potassium phosphate, sodium phosphate, magnesium sulfate, ferrous sulfate, and manganese sulfate may be used. [0044]
  • The cultivation is performed usually under aerobic conditions such as shaking culture and aeration and stirring culture, at pH of 5 to 9, and at a temperature of 20 to 40° C. It is usually completed for 24 to 120 hours. [0045]
  • The culture includes cells and the culture medium, and is preferably the culture medium. [0046]
  • The recover of L-phenylalanine from the culture may be performed according to combination of known methods such as ionexchange resin method and precipitation method.[0047]
  • EXAMPLES
  • The present invention is described in details in reference to examples. Methods for cultivation of [0048] Methylophilus methylotrophus and for analysis of L-phenylalanine which were used in the following examples are as follows:
  • <1> Cultivation in Tubes [0049]
  • 1. Seed Culture [0050]
  • The strain was grown on plates or slants with 121(Fe2)-medium agar containing 1% methanol at 30° C. for 48-72 hours. And then the strain was inoculated into 5 ml 121(Fe2)-medium containing 2% methanol used as the seed medium in tubes with capacity of 40 ml. The seed culture was incubated on a rotary shaker at 37° C. for 18 hours. [0051]
  • 2. Fermentation in Tubes [0052]
  • The cultivation of L-phenylalanine producer was carried out at 37° C. in 5 ml of 121(Fe2)-medium containing 2% methanol and 3% calcium carbonate in tubes with capacity of 40 ml. Twenty four hours after the start of cultivation, the another portion of 2% methanol was added and the cultivation was continued for further 48 hours at 37° C. on a rotary shaker. [0053]
  • The composition of 121(Fe2)-medium containing 2% methanol and 3% calcium carbonate (1 liter): [0054]
    K2HPO4.3H2O 1.57 g
    KH2PO4 0.62 g
    (NH4)2SO4 3 g
    NaCl 0.1 g
    MgSO4.7H2O 0.2 g
    CaCl2 0.025 g
    EDTA-Na2 5 mg
    FeSO4.7H2O 3 mg
    MnSO4.5H2O 0.01 mg
    ZnSO4.7H2O 0.07 mg
    Na2MoO4.2H2O 0.01 mg
    H3BO3 0.01 mg
    CoCl2.6H2O 0.005 mg
    CuSO4.5H2O 0.005 mg
    Methanol 20 ml
    (filter sterilized)
    CaCO3 30 g
    pH 7.0
  • <2> Analysis of L-phenylalanine in Fermentation Broth. [0055]
  • 1. Sample Preparation [0056]
  • The samples of fermentation broth were centrifuged 15 min on model 5415C microfuge (Eppendorf) with the aim to remove cells and debris. Supernatant was used for high performance liquid chromatography (HPLC) analysis. [0057]
  • 2. Chromatographic Determination of L-phenylalanine [0058]
  • The chromatographic system consisted of a HPLC pump model 30 (Gilson), and model 2151 variable wavelength monitor operated at 245 nm (LKB). Samples were injected using model 7410 injector with 1 μl internal sample loop (Rheodyne). Column was thermostated with laboratory made water-jacketed thermostat at 45° C. [0059]
  • Glass cartridge system with 150 mm×3.9 mm I.D. glass cartridges packed with 5 μm Separon C18 sorbent (Tessek) was used for all separations. Eluent consisted of 0.001 M CuSO[0060] 4 in water/acetonitril (80/20(v/v)).
  • Samples of fermentation broth were centrifuged for 5 min at 13,000×g and injected without further preparation. [0061]
  • The data were processed using an IBM PC/AT compatible data station with model 960 Interface and Nelson PC Integrator software (PE Nelson). Peaks were calculated using external standard technique. [0062]
  • Example 1
  • Construction of [0063] Methylophilus methylotrophus Mutant Strains Which Have Ability to Produce L-phenylalanine
  • <1> Mutagenesis and Selection of Mutants Resistant to DL-p-fluorophenylalanine, Aromatic Amino Acid Analog. [0064]
  • The [0065] Methylophilus methylotrophus AS-1 (NCIB 10515; ATCC 53528) strain was tested for the sensivity to the DL-p-fluorophenylalanine, an aromatic amino acid analog. The sensivity has been tested on 121(Fe2)-agar medium containing different concentrations of DL-p-fluorophenylalanine. The 108 c.f.u./ml of M. methylotrophus bacteria were plated and grown at +30° C. for 3 days. The 1 mg/ml of the DL-p-fluorophenylalanine totally inhibited the growth of the bacteria lawn. To select the analog-resistant mutants, the 108 bacteria of M. methylotrophus strain was seeded on plates carrying 2 mg/ml of DL-p-fluorophenylalanine. The several crystals of N-methyl-N′-nitro-N-nitrosoguanidin (hereinafter abbreviated to NG) mutagen was placed in the middle of the plate. After 4-5 days at 30° C., the plates were analyzed. The bacteria did not show growth near NG mutagen, but at 3-4 cm from it, the analog resistant mutant colonies grew. The big colonies were picked up and purified on the same media with analog DL-p-fluorophenylalanine. The M. methylotrophus DL-p-fluorophenylalanine resistant (hereinafter abbreviated to pFpR) mutants were cultivated and concentration of L-phenylalanine in the fermentation medium was measured as described above. The best M. methylotrophus pFpR mutant No. 227 produced 30 mg/L of L-phenylalanine, near 1 g/L of L-valine, and 0.2 g/L of L-leucine, L-isoleucine and L-alanine. The thin layer chromatography approved HPLC analysis results.
  • <2> Mutagenesis and Selection of the [0066] Methylophilus methylotrophus Mutants Resistant to the High Concentrations of L-phenylalanine in the Growing Medium.
  • The [0067] Methylophilus methylotrophus DL-p-fluorophenylalanine resistant mutants produced L-phenylalanine but was sensitive to the high concentrations of L-phenylalanine if it was presented in the medium. The 0.1 M of L-phenylalanine totally inhibited the growth of the M. methylotrophus pFpR mutant No. 227 if it was added into the agarized 121-medium.
  • In order to eliminate this sensitivity and to increase strains productivity, the mutants resistant to the higher concentrations of L-phenylalanine presented in growing medium were selected. As a parental strain for the selection of the L-phenylalanine resistant mutants (hereinafter abbreviated to phe[0068] R), the M. methylotrophus No. 227 (pFpR mutant strain) producing a little amount (30 mg/l) of L-phenylalanine was used. The selection medium was the 121(Fe2)-agar medium with 1% methanol and 0.05 M L-phenylalanine. The mutagenesis by NG was performed as it was described above. The L-phenylalanine resistant mutant colonies were several times purified on the same medium and later on medium without 0.05 M of L-phenylalanine. The pheR-marker in mutants was stable inherited and not lost without selection pressure. The selected M. methylotrophus pFpR pheR mutants were cultivated and the concentration of L-phenylalanine in the fermentation medium was measured as described above. The best M. methylotrophus pFpR pheR mutant No. 227-16 carrying the mutation of the resistance to the high L-phenylalanine concentrations produced 0.4 g/l of L-phenylalanine. Thus, the pheR-mutation, as the second mutation in M. methylotrophus pFpR pheR mutant No. 227-16, elevated the L-phenylalanine production more than 10 times: the pFpR-mutant (No. 227) produced 30 mg/l of L-phenylalanine and the double pFpR pheR-mutant (No. 227-16) produced 400 mg/l of L-phenylalanine.
  • It was found that the Methylophilus methylotrophus pFp[0069] R pheR mutant strain No. 227-16 was also resistant to a 0.5 g/l meta-fluorophenylalanine besides resistance to 2 g/l of DL-p-fluorophenylalanine and to 0.05 M of L-phenylalanine. However, strain No. 227-16 showed only a slight growth on 1 g/l of meta-fluorophenylalanine. The new mutants which were resistant to 1 g/L of meta-fluorophenylalanine (hereinafter abbreviated to mFpR) were isolated from the strain No. 227-16 after NG-mutagenesis as it was described above. The resulted new M. methylotrophus pFpR pheR mFpR mutant strain No. 227-16-10, produced the same quantity of L-phenylalanine as its predecessor (0.4 g/l).
  • A new [0070] M. methylotrophus pFpR pheR mFpR pheRR mutant strain No. 227-16-10-11, which was resistant to the higher concentrations of L-phenylalanine (0.1 M) (hereinafter abbreviated to pheRR), was isolated from the strain No. 227-16-10 after NG-mutagenesis as it was described above. The pheRR-mutant strain produced in tubes 0.5-0.7 g/l L-phenylalanine, 0.3 g/l L-valine, 0.2 g/l L-leucine and less than 0.1 g/l of L-isoleucine, L-alanine and L-glutamic acid.
  • The new [0071] M. methylotrophus pFpR-pheR-mFpR-pheRR-cinR mutant strain No. 227-16-10-11-cin8, which was resistant to cinnamic acid (50 mg/L), the chemical structure analog of L-phenylalanine, (hereinafter abbreviated to cinR) was isolated from a No. 227-16-10-11 strain after NG-mutagenesis as it was described above. The cinR-mutant strain produced in tubes 0.8-0.9 g/l L-phenylalanine and 0.6 g/l L-valine.
  • The strains Nos. 227, 227-16, 227-16-10, 227-16-10-11 and 227-16-10-11-cin8 have been deposited in the Russian National Collection of Industrial Microorganisms (VKPM) on Feb. 10[0072] th, 2000 (converted to a deposition according to the provisions of Budapest Treaty on Jul. 18, 2000) under the accession numbers VKPMB-7909, VKPMB-7910, VKPM B-7911, VKPM B-7912, and VKPM B-7913, respectively.

Claims (10)

What is claimed is:
1. A bacterium belonging to the genus Methylophilus, which has an ability to produce L-phenylalanine and is resistant to a phenylalanine analog.
2. The bacterium according to
claim 1
, which is resistant to the phenylalanine analog and L-phenylalanine.
3. The bacterium according to
claim 1
, which is resistant to DL-p-fluorophenylalanine.
4. The bacterium according to
claim 2
, which is obtained by selecting a strain which is resistant to the phenylalanine analog and L-phenylalanine from bacteria belonging to the genus Methylophilus, wherein said selection is performed at least once for each of the phenylalanine analog and L-phenylalanine in any order.
5. The bacterium according to
claim 2
, which is resistant to DL-p-fluorophenylalanine and m-fluorophenylalanine.
6. The bacterium according to
claim 5
, which is obtained by selecting a strain which is resistant to DL-p-fluorophenylalanine, m-fluorophenylalanine and L-phenylalanine from bacteria belonging to the genus Methylophilus, wherein said selection is performed at least once for each of DL-p-fluorophenylalanine, m-fluorophenylalanine and L-phenylalanine in any order.
7. The bacterium according to
claim 2
, which is resistant to DL-p-fluorophenylalanine, m-fluorophenylalanine and cinnamic acid.
8. The bacterium according to
claim 7
, which is obtained by selecting a strain which is resistant to DL-p-fluorophenylalanine, m-fluorophenylalanine, cinnamic acid and L-phenylalanine from bacteria belonging to the genus Methylophilus, wherein said selection is performed at least once for each of DL-p-fluorophenylalanine, m-fluorophenylalanine, cinnamic acid and L-phenylalanine in any order.
9. The bacterium according to any one of
claims 1
to
8
, which is Methylophilus methylotrophus.
10. A method for producing L-phenylalanine, comprising the steps of:
culturing the bacterium as defined in any of
claims 1
to
9
in a culture medium to produce and accumulate L-phenylalanine in a culture, and
recovering L-phenylalanine from the culture.
US09/791,707 2000-03-03 2001-02-26 Method for producing L-phenylalanine Expired - Fee Related US6350596B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2000105201 2000-03-03
RU2000105201/13A RU2202607C2 (en) 2000-03-03 2000-03-03 Strain of bacterium methylophilus methylotrophus as producer of l-phenylalanine (variants), method of l-phenylalanine preparing

Publications (2)

Publication Number Publication Date
US20010044139A1 true US20010044139A1 (en) 2001-11-22
US6350596B2 US6350596B2 (en) 2002-02-26

Family

ID=20231339

Family Applications (1)

Application Number Title Priority Date Filing Date
US09/791,707 Expired - Fee Related US6350596B2 (en) 2000-03-03 2001-02-26 Method for producing L-phenylalanine

Country Status (8)

Country Link
US (1) US6350596B2 (en)
EP (1) EP1134283B1 (en)
JP (1) JP2001245658A (en)
KR (1) KR20010086590A (en)
CN (1) CN1162538C (en)
BR (1) BR0100816A (en)
DE (1) DE60113323T2 (en)
RU (1) RU2202607C2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090137010A1 (en) * 2007-09-27 2009-05-28 Rustem Saidovich Shakulov Method for producing amino acids using bacterium of the enterobacteriaceae family
WO2019168203A1 (en) 2018-03-02 2019-09-06 国立研究開発法人科学技術振興機構 Method for producing 4-aminocinnamic acid, and vector and host cell used in same

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2250266C2 (en) * 1999-04-09 2005-04-20 Адзиномото Ко., Инк. Method for production of l-amino acid
RU2333950C2 (en) * 2005-12-27 2008-09-20 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО АГРИ) METHOD OF PRODUCTION OF AROMATIC L-AMINO ACIDS USING BACTERIUM BELONGING TO GENUS Methylophilus
EP3509582B1 (en) * 2016-09-06 2023-12-20 Axsome Malta Ltd. Solvate form of (r)-2-amino-3-phenylpropyl carbamate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0035831B1 (en) * 1980-03-07 1986-01-08 Imperial Chemical Industries Plc Method for making genetically modified microorganisms
US4824786A (en) * 1984-09-14 1989-04-25 The Regents Of The University Of Minnesota Methylotroph cloning vehicle
JPS61128897A (en) * 1984-11-27 1986-06-16 Ajinomoto Co Inc Production of l-phenylalanine by fermentation method
GB2194247A (en) * 1986-08-19 1988-03-02 Allelix Inc Mutant microorganisms
RU2250266C2 (en) * 1999-04-09 2005-04-20 Адзиномото Ко., Инк. Method for production of l-amino acid

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090137010A1 (en) * 2007-09-27 2009-05-28 Rustem Saidovich Shakulov Method for producing amino acids using bacterium of the enterobacteriaceae family
US9376695B2 (en) 2007-09-27 2016-06-28 Ajinomoto Co., Inc. L-amino acid producing bacterium
US9708637B2 (en) 2007-09-27 2017-07-18 Ajinomoto Co., Inc. Method for producing lower alkyl ester
WO2019168203A1 (en) 2018-03-02 2019-09-06 国立研究開発法人科学技術振興機構 Method for producing 4-aminocinnamic acid, and vector and host cell used in same

Also Published As

Publication number Publication date
US6350596B2 (en) 2002-02-26
BR0100816A (en) 2001-11-06
RU2202607C2 (en) 2003-04-20
EP1134283A1 (en) 2001-09-19
CN1317568A (en) 2001-10-17
DE60113323D1 (en) 2005-10-20
DE60113323T2 (en) 2006-06-29
KR20010086590A (en) 2001-09-13
JP2001245658A (en) 2001-09-11
EP1134283B1 (en) 2005-09-14
CN1162538C (en) 2004-08-18

Similar Documents

Publication Publication Date Title
RU2207371C2 (en) Method for preparing l-amino acids of l-glutamic acid family, strain of bacterium escherichia coli as producer of l-amino acid (variants)
KR100249532B1 (en) Process for producing l-threonine with strains of e coli resistant to phenylalanine and leucine
KR100866479B1 (en) Method for producing L-glutamic acid by fermentation accompanied by precipitation
KR100452572B1 (en) Production of tryptophan by Escherichia coli
KR20050059685A (en) E.coli mutant strain containing mutant genes related with tryptophan biosynthesis and production method of tryptophan by using the same
RU2209248C2 (en) Method for preparing l-methionine, strain of bacterium escherichia coli vkpm b-8125 as producer of l-methionine
EP1654376A2 (en) A process for preparing l-threonine
WO2005014841A1 (en) Process for the preparation of l-threonine
US4636466A (en) Phenylalanine ammonia lyase-producing microbial cells
US6350596B2 (en) Method for producing L-phenylalanine
Motoyama et al. Amino acid production from methanol by Methylobacillus glycogenes mutants: isolation of L-glutamic acid hyper-producing mutants from M. glycogenes strains, and derivation of L-threonine and L-lysine-producing mutants from them
KR0150465B1 (en) Process for producing amino acids
WO2001014525A1 (en) Microorganisms and methods for producing threonine
WO2000009661A1 (en) Novel microorganisms and method for producing l-threonine using the same
KR100438146B1 (en) L-leucine producing microorganism corynebacterium glutamicum ch25 having tolerance against norleucine, alpha-aminobutyric acid and l-arginine hydroxamate
KR20060015582A (en) Process for producing l-glutamic acid
Hagino et al. L-_?? _yrosine Production by Polyauxotrophic Mutants of Corynebacterium glutamicum
KR960016871B1 (en) L-valine producing microorganisms and process for producing l-valine by fermentation
KR100793215B1 (en) Mutant bacterial strains l-lysine production
KR900008251B1 (en) Process for preparing l-triptophan by microorganism
CA2375128A1 (en) A global regulator used to enhance the synthesis of aromatic substances
Park et al. L-phenylalanine production by auxotrophic regulatory mutants of Escherichia coli—L-phenylalanine production by mutants of E. coli
HU215248B (en) Process for producing l-lysine
KR0145011B1 (en) L-Tryptophan-producing strains susceptible to L-arginine
US20060252133A1 (en) Process for the preparation of l-threonine

Legal Events

Date Code Title Description
AS Assignment

Owner name: AJINOMOTO CO., INC, JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:IOMANTAS, YURGIS ANTANAS VLADOVICH;ABALAKINA, ELENA GEORGIEVNA;REEL/FRAME:012029/0400

Effective date: 20010118

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20140226